Treatment of hypercalcemia of malignancy with bisphosphonates

被引：51

作者：

Berenson, JR ^{[1
]}

机构：

[1] Cedars Sinai Med Ctr, Div Hematol Oncol, Los Angeles, CA 90048 USA

来源：

SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 06期

关键词：

D O I：

10.1053/sonc.2002.37417

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：12 / 18

页数：7

共 38 条

[1]

BAJORUNAS DR, 1990, SEMIN ONCOL, V17, P16

[2]

Berenson JR, 2001, CANCER, V91, P144, DOI 10.1002/1097-0142(20010101)91:1<144::AID-CNCR19>3.0.CO

[3]

2-Q

[4]

Berenson JR, 2001, SEMIN ONCOL, V28, P25

[5] A dose-finding study of zoledronate in hypercalcemic cancer patients [J].

Body, JJ ;

Lortholary, A ;

Romieu, G ;

Vigneron, AM ;

Ford, J .

JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (09) :1557-1561

[6] TREATMENT OF MALIGNANCY-ASSOCIATED HYPERCALCEMIA WITH INTRAVENOUS AMINOHYDROXYPROPYLIDENE DIPHOSPHONATE [J].

BODY, JJ ;

BORKOWSKI, A ;

CLEEREN, A ;

BIJVOET, OLM .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (08) :1177-1183

[7]

BOUNAMEAUX HM, 1983, LANCET, V1, P471

[8]

Capparelli C, 2000, CANCER RES, V60, P783

[9] Conventional treatment of hypercalcemia of malignancy [J].

Davidson, TG .

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2001, 58 (22) :S8-S15

[10] MANAGEMENT OF SEVERE HYPERCALCEMIA [J].

DAVIS, KD ;

ATTIE, MF .

CRITICAL CARE CLINICS, 1991, 7 (01) :175-190

← 1 2 3 4 →